Mineralys Therapeutics (MLYS) Net Cash Flow (2022 - 2026)
Quarterly results put Net Cash Flow at -$60.1 million for Q1 2026, down 218.12% from a year ago — trailing twelve months through Mar 2026 was -$52.2 million (down 170.02% YoY), and the annual figure for FY2025 was $58.8 million, down 9.19%.
Mineralys Therapeutics has reported Net Cash Flow over the past 5 years, most recently at -$60.1 million for Q1 2026.
- Net Cash Flow reached -$60.1 million in Q1 2026 per MLYS's latest filing, down from -$44.7 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $115.9 million in Q3 2025 and bottomed at -$79.3 million in Q3 2022.
- Median Net Cash Flow over the past 5 years was $5.4 million (2022), compared with a mean of $6.0 million.
- The largest annual shift saw Net Cash Flow surged 832.74% in 2023 before it crashed 365.83% in 2025.
- Over 5 years, Net Cash Flow stood at $38.7 million in 2022, then crashed by 195.48% to -$37.0 million in 2023, then soared by 145.46% to $16.8 million in 2024, then plummeted by 365.83% to -$44.7 million in 2025, then plummeted by 34.53% to -$60.1 million in 2026.
- Business Quant data shows Net Cash Flow for MLYS at -$60.1 million in Q1 2026, -$44.7 million in Q4 2025, and $115.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -152.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Mineralys Therapeutics | 2.50 Bn | 2.50 Bn | - | -60.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.14 Mn |
| Mar 31, 2026 | -60.14 Mn |
| Dec 31, 2025 | -44.70 Mn |
| Dec 31, 2025 | -44.70 Mn |
| Sep 30, 2025 | 115.88 Mn |
| Sep 30, 2025 | 115.88 Mn |
| Jun 30, 2025 | -63.26 Mn |
| Jun 30, 2025 | -63.26 Mn |
| Mar 31, 2025 | 50.92 Mn |
| Mar 31, 2025 | 50.92 Mn |
| Dec 31, 2024 | 16.82 Mn |
| Dec 31, 2024 | 16.82 Mn |
| Sep 30, 2024 | 29.42 Mn |
| Sep 30, 2024 | 29.42 Mn |
| Jun 30, 2024 | -22.56 Mn |
| Jun 30, 2024 | -22.56 Mn |
| Mar 31, 2024 | 41.11 Mn |
| Mar 31, 2024 | 41.11 Mn |
| Dec 31, 2023 | -37.00 Mn |
| Dec 31, 2023 | -37.00 Mn |
| Sep 30, 2023 | -14.84 Mn |
| Sep 30, 2023 | -14.84 Mn |
| Jun 30, 2023 | -37.11 Mn |
| Jun 30, 2023 | -37.11 Mn |
| Mar 31, 2023 | 50.55 Mn |
| Mar 31, 2023 | 50.55 Mn |
| Dec 31, 2022 | 38.75 Mn |
| Dec 31, 2022 | 38.75 Mn |
| Sep 30, 2022 | -79.31 Mn |
| Sep 30, 2022 | -79.31 Mn |
| Jun 30, 2022 | 112.18 Mn |
| Jun 30, 2022 | 112.18 Mn |
| Mar 31, 2022 | 5.42 Mn |
| Mar 31, 2022 | 5.42 Mn |